BenefitsPRO: Employee Benefits News, Trends & Sales Tips

Eli Lilly's big move: Drugmaker now offering obesity drug Zepbound direct to consumers

By Alan Goforth

The pharmaceutical giant has launched a telehealth-connected website to allow patients to directly order the weight loss drug, as well as insulin products and a migraine drug, direct from the company.

Read Story

News

Michigan health insurers cannot deny new cancer treatments: Will other states step up?

Update

Claim denied? Health insurers must promptly hand over records, but most don't

Recommended Just For You

Consumer Driven Health Care Stories

January 08, 2024

Sharp uptick in ER visits, hospitalizations for COVID, flu & RSV (and gaining momentum)

A federal mask mandate is unlikely, but health officials and hospitals in California, Illinois, Massachusetts, and New York have again told staff and patients to don masks. And if you feel ill, stay home, recommends a health official.

Read

January 05, 2024

Blue Cross Blue Shield put patient through 'prior authorization hell' over infusions

Prior authorization was conceived to rein in health care costs by eliminating duplicative treatment, however, critics worry it has now become a way for insurance companies to save money, often at the expense of patients' lives.

Read

January 05, 2024

Lawmakers applaud $35 insulin cap, now in effect, after drugmakers slashed prices

Sens. Tim Kaine and Mark R. Warner, who both have championed to lower the cost of prescription drugs, applauded Sanofi, Novo Nordisk and Eli Lilly – the three major insulin manufacturers – for slashing prices, effective Jan. 1, 2024.

Read

January 04, 2024

Need mental health support? Employers now have an app for that – AI wellness chatbot

Due to a nationwide shortage of therapists, about a third of U.S. employers say they offer employees AI-based wellness and mental health programs, yet researchers say there isn't enough evidence that the programs work.

Read

January 04, 2024

Biopharma breakthrough year: FDA approved 50% more novel drugs in 2023

The Food and Drug Administration approved 55 new treatments in 2023, representing a nearly 50% increase from the year before, with Pfizer gaining the highest number of high-profile approvals covering a wide range of illnesses.

Read

January 04, 2024

IN-DEPTH – Benefits 2023: The Year in Review (and a look ahead)

Health and retirement benefits are more important now than they've ever been as employers compete for top talent, with employees' mental health now taking a more prominent place in a company's benefits package.

Read

January 03, 2024

Drugmakers – Pfizer, Sanofi, Takeda, more – will raise 500 drug prices in January

Despite the Biden administration's numerous initiatives to crack down on the high cost of drugs, several big drugmakers will hike prices this month, with Pfizer announcing over a quarter of the increases.

Read

‹ ‹ PREV 96 97 98 ... 734 › NEXT ›

Consumer Driven Health Care

Top Consumer Driven Health Care Stories

Eli Lilly's big move: Drugmaker now offering obesity drug Zepbound direct to consumers

Michigan health insurers cannot deny new cancer treatments: Will other states step up?

Claim denied? Health insurers must promptly hand over records, but most don't

Recommended Just For You

Consumer Driven Health Care Stories

Sharp uptick in ER visits, hospitalizations for COVID, flu & RSV (and gaining momentum)

Blue Cross Blue Shield put patient through 'prior authorization hell' over infusions

Lawmakers applaud $35 insulin cap, now in effect, after drugmakers slashed prices

Need mental health support? Employers now have an app for that – AI wellness chatbot

Biopharma breakthrough year: FDA approved 50% more novel drugs in 2023

IN-DEPTH – Benefits 2023: The Year in Review (and a look ahead)

Drugmakers – Pfizer, Sanofi, Takeda, more – will raise 500 drug prices in January